pf-06821497
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Apr 19, 2018 (NCT03460977)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
COc1cc(C)[nH]c(=O)c1CN1CCc2c(Cl)cc([C@H](OC)C3COC3)c(Cl)c2C1=O- Mol. weight
- 467.35 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4080228 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07028853 | Phase 3 | Sep 28, 2025 | Pfizer |
| NCT06629779 | Phase 3 | Oct 22, 2024 | Pfizer |
| NCT06551324 | Phase 3 | Oct 21, 2024 | Pfizer |
| NCT06392230 | Phase 1 | Aug 30, 2024 | Pfizer |
| NCT05767905 | Phase 1 | Mar 17, 2023 | Pfizer |
| NCT03460977 | Phase 1 | Apr 19, 2018 | Pfizer |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 6 | 6 | 2 | 2018 |
1 organizations
Page 1 / 1